CCL2 and neoplasm: Glioblastoma cell-derived EVs upregulated the expression of the pro-tumor genes in microglia cells, including the CXCL1/10, CCL2/CCL5, and IL-6, and downregulated immune response-associated genes, such as IL-16, IL-23, and IL-2740.